Zbigniew K Wszolek Selected Research

Stroke (Strokes)

11/2020

Plasma neurofilament light predicts mortality in patients with stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zbigniew K Wszolek Research Topics

Disease

76	Parkinson Disease (Parkinson's Disease) 04/2024 - 02/2002
32	Parkinsonian Disorders (Parkinsonism) 10/2022 - 08/2002
24	Frontotemporal Dementia (Semantic Dementia) 04/2024 - 05/2007
19	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 02/2002
16	Dementia (Dementias) 01/2023 - 12/2008
13	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2024 - 06/2008
13	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 01/2008
11	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 09/2006
11	Multiple System Atrophy 01/2023 - 01/2010
11	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2015 - 09/2008
10	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 01/2010
9	Essential Tremor (Essential Tremors) 02/2024 - 09/2009
8	Tremor (Tremors) 01/2022 - 02/2002
7	Leukoencephalopathies 12/2022 - 12/2020
6	Synucleinopathies 01/2023 - 01/2014
6	Cognitive Dysfunction 01/2021 - 11/2009
5	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 08/2022 - 10/2020
4	Disease Progression 04/2024 - 07/2014
4	Dyskinesias (Dyskinesia) 09/2023 - 10/2005
4	Tauopathies 04/2023 - 01/2016
4	Atrophy 10/2022 - 03/2012
4	Ataxia (Dyssynergia) 09/2022 - 10/2020
4	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2022 - 01/2002
4	Dystonia (Limb Dystonia) 01/2022 - 10/2009
4	Corticobasal Degeneration 12/2020 - 08/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2014 - 03/2012
3	Weight Loss (Weight Reduction) 01/2018 - 08/2017
3	Motor Neuron Disease (Primary Lateral Sclerosis) 09/2017 - 01/2010
3	Sarcoma (Soft Tissue Sarcoma) 09/2014 - 11/2011
2	Neuroinflammatory Diseases 04/2024 - 10/2018
2	Cerebellar Ataxia (Dysmetria) 10/2022 - 01/2022
2	Movement Disorders (Movement Disorder) 01/2021 - 10/2016
2	Disease Susceptibility (Diathesis) 01/2021 - 10/2013
2	COVID-19 01/2021 - 01/2020
2	Hallucinations (Hallucination) 01/2018 - 08/2016
2	Hypoventilation 09/2017 - 08/2017
2	Hereditary Diffuse Leukoencephalopathy with Spheroids 08/2012 - 12/2011
2	Dysarthria (Spastic Dysarthria) 05/2011 - 11/2009
2	Pallidopontonigral Degeneration 07/2010 - 05/2007
2	Hypokinesia (Bradykinesia) 05/2003 - 02/2002
1	Asymptomatic Diseases 06/2024
1	Inflammation (Inflammations) 04/2024
1	Vascular Diseases (Vascular Disease) 03/2024
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2023
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2022

Drug/Important Bio-Agent (IBA)

26	Phosphotransferases (Kinase)IBA 04/2024 - 04/2005
25	Leucine (L-Leucine)FDA Link 04/2024 - 04/2005
19	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2023 - 08/2007
18	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 01/2003
16	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2008
16	SynucleinsIBA 01/2022 - 08/2010
12	ProgranulinsIBA 01/2020 - 08/2007
11	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2023 - 09/2008
10	UbiquitinIBA 03/2024 - 09/2007
10	Apolipoproteins E (ApoE)IBA 11/2021 - 09/2006
9	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2007
9	alpha-SynucleinIBA 01/2023 - 02/2009
6	Amyloid (Amyloid Fibrils)IBA 03/2024 - 01/2013
5	Dopamine (Intropin)FDA LinkGeneric 09/2023 - 02/2002
5	polyglutamineIBA 01/2022 - 01/2002
4	Macrophage Colony-Stimulating FactorIBA 01/2022 - 12/2011
4	ApolipoproteinsIBA 10/2018 - 09/2006
3	Protein Isoforms (Isoforms)IBA 04/2023 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2020
3	Ataxin-3IBA 01/2022 - 10/2020
3	Apolipoprotein E4IBA 11/2021 - 11/2020
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 08/2010
3	Ataxin-2IBA 10/2014 - 01/2002
3	Dihydroxyphenylalanine (Dopa)IBA 07/2011 - 08/2002
2	EnzymesIBA 01/2023 - 03/2012
2	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2023 - 01/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2022 - 01/2016
2	Glutamine (L-Glutamine)FDA Link 09/2022 - 08/2011
2	Glutamic Acid (Glutamate)FDA Link 09/2022 - 01/2016
2	IGF-I-IGFBP-3 complex FDA Link 01/2022 - 03/2014
2	Serine (L-Serine)FDA Link 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2013
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 01/2018
2	AcetylcholinesteraseIBA 01/2018 - 07/2010
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 12/2010
2	PTEN-induced putative kinaseIBA 01/2017 - 11/2014
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 01/2016
2	tau Proteins (tau Protein)IBA 01/2016 - 08/2015
2	Amino Acids FDA Link 08/2015 - 01/2013
2	ChromatinIBA 09/2014 - 11/2011
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2014 - 01/2014
2	Dopamine Agonists (Dopamine Agonist)IBA 12/2006 - 01/2003
1	GlucocorticoidsIBA 06/2024
1	OsteopontinIBA 04/2024
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2024
1	neuromelaninIBA 01/2024
1	Monoclonal AntibodiesIBA 12/2023
1	Protein Kinases (Protein Kinase)IBA 06/2023
1	ImmunosorbentsIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	AutoantibodiesIBA 10/2022

Therapy/Procedure

18	Therapeutics 06/2024 - 03/2003
4	Hematopoietic Stem Cell Transplantation 06/2024 - 12/2020
2	Deep Brain Stimulation 02/2024 - 01/2016
1	Denervation 04/2024